Mumbai (Maharashtra) [India], November 11: Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION DeNovo and SELUTION4ISR trials at Transcatheter Cardiovascular Therapeutics® (TCT®) 2025, the annual scientific symposium of